1. THU0645 Impact of second-line therapy with abatacept versus other targeted dmards on the risk for infection-related hospitalizations and associated costs among ra patients in the united states. (12th June 2018) Authors: Paul, D.; McDonald, L.; Marshall, A.; Curtice, T.; Lingohr-Smith, M.; Menges, B.; Lin, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗